Status:

COMPLETED

Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Locally Advanced Tumors

Metastatic Solid Tumors

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The primary purpose of this study is to investigate the Dose Limiting Toxicities (DLTs), pharmacokinetics (PK), and pharmacodynamics (PD) of MK-2206 administered orally to participants with advanced s...

Eligibility Criteria

Inclusion

  • Participant must have confirmed locally advanced or metastatic solid tumors that have failed to respond to standard therapy, have gotten worse or have come back after existing therapy
  • Has normal organ function; is no greater than 2 on the ECOG Performance Scale
  • Has a negative blood or urine pregnancy test within 72 hours of receiving the first dose of study drug if participant is female
  • Is able to swallow capsules and has no surgical or bodily condition that will prevent the patient from swallowing and absorbing oral medications on an ongoing basis

Exclusion

  • Participant has had chemotherapy, radiotherapy, biological therapy or surgery within 4 weeks of starting the study and has not recovered from adverse events caused by the treatment
  • Is currently participating or has participated in a study with an investigational compound or device within 30 days
  • Has a primary central nervous system tumor
  • Has a history or current evidence of heart disease, slow heart rate or untreated high blood pressure
  • Is a known diabetic who is taking insulin or oral antidiabetic therapy
  • Is pregnant or breastfeeding or planning to become pregnant during the study
  • Is HIV-positive
  • Has known history of Hepatitis B or C or active Hepatitis A
  • Is receiving treatment with oral corticosteroids

Key Trial Info

Start Date :

April 15 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 11 2011

Estimated Enrollment :

104 Patients enrolled

Trial Details

Trial ID

NCT00670488

Start Date

April 15 2008

End Date

July 11 2011

Last Update

April 1 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.